id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
701,,,,,,,,,,,,,,,2024-05-14T13:54:05+06:00,BSH - BSH - R180318114,,Fulvestrant  +  Palbociclib + ZA,2023-09-26,,"Received ADCT with Docetaxel + Doxorubicin upto 10.06.2005 (Total 6 cycles). 12 cycles of
Zoledronic Acid till 2019 due to bone mets. On Anastrozole since 2018 (irregular).
2023- June: Now on 2nd line ChT with Gemcitabine + Carboplatin+ZA from 07.06.2023. C2D8 is due on
09.07.2023 > PD> changed schedule, Now on Fulvestrant + Palbociclib started from 26.09.23, ZA 12
cycle given. C5 is due on 26.12.23",,,2024-01-04,,,,,Breast,111,Upper middle class,BSBSC-240000111,RULI CHOWDHURY,1714377460,1968-03-18,Female,,,,,Dr Md Arifur Rahman,BSH,,2nd Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,,Alive,,,,,,,,,,,,,,,,,,CA15.3,1297.6,,2023-05-18,701.0
701,,,,,,,,,,,,,,,2024-05-14T13:54:05+06:00,BSH - BSH - R180318114,,Fulvestrant  +  Palbociclib + ZA,2023-09-26,,"Received ADCT with Docetaxel + Doxorubicin upto 10.06.2005 (Total 6 cycles). 12 cycles of
Zoledronic Acid till 2019 due to bone mets. On Anastrozole since 2018 (irregular).
2023- June: Now on 2nd line ChT with Gemcitabine + Carboplatin+ZA from 07.06.2023. C2D8 is due on
09.07.2023 > PD> changed schedule, Now on Fulvestrant + Palbociclib started from 26.09.23, ZA 12
cycle given. C5 is due on 26.12.23",,,2024-01-04,,,,,Breast,111,Upper middle class,BSBSC-240000111,RULI CHOWDHURY,1714377460,1968-03-18,Female,,,,,Dr Md Arifur Rahman,BSH,,2nd Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,,Alive,,,,,,,,,,,,,,,,,,CA15.3,1530.0,,2023-05-19,701.0
701,,,,,,,,,,,,,,,2024-05-14T13:54:05+06:00,BSH - BSH - R180318114,,Fulvestrant  +  Palbociclib + ZA,2023-09-26,,"Received ADCT with Docetaxel + Doxorubicin upto 10.06.2005 (Total 6 cycles). 12 cycles of
Zoledronic Acid till 2019 due to bone mets. On Anastrozole since 2018 (irregular).
2023- June: Now on 2nd line ChT with Gemcitabine + Carboplatin+ZA from 07.06.2023. C2D8 is due on
09.07.2023 > PD> changed schedule, Now on Fulvestrant + Palbociclib started from 26.09.23, ZA 12
cycle given. C5 is due on 26.12.23",,,2024-01-04,,,,,Breast,111,Upper middle class,BSBSC-240000111,RULI CHOWDHURY,1714377460,1968-03-18,Female,,,,,Dr Md Arifur Rahman,BSH,,2nd Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,,Alive,,,,,,,,,,,,,,,,,,CA15.3,1451.6,,2023-07-07,701.0
